BioStock: Neola Medical receives ISO certification

Neola Medical is working hard towards the goal of obtaining market approval in the US with Neola, the company’s product for monitoring the lungs of premature babies. The company have now announced that the quality management system has been certified according to ISO 13485, a milestone on the road to CE marking and market approval by the FDA in the US. BioStock contacted the company’s CEO Hanna Sjöström to find out more about what this means.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/11/neola-medical-receives-iso-certification/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se